The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[3-Cyclopentyl-2-(3,4-dichlorophenyl)-propionylamino]-thiazol-4-yl}-acetic acid ethyl ester ID: ALA1098742
PubChem CID: 46221804
Max Phase: Preclinical
Molecular Formula: C21H24Cl2N2O3S
Molecular Weight: 455.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)Cc1csc(NC(=O)C(CC2CCCC2)c2ccc(Cl)c(Cl)c2)n1
Standard InChI: InChI=1S/C21H24Cl2N2O3S/c1-2-28-19(26)11-15-12-29-21(24-15)25-20(27)16(9-13-5-3-4-6-13)14-7-8-17(22)18(23)10-14/h7-8,10,12-13,16H,2-6,9,11H2,1H3,(H,24,25,27)
Standard InChI Key: MLKRLDYABJPSAM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
19.1272 -9.2611 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.0425 -8.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7918 -8.1070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3441 -8.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9322 -9.4332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6493 -9.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1653 -8.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3122 -10.0516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4663 -9.2134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3276 -8.0322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6128 -8.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6128 -9.2680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8979 -8.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8979 -7.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1872 -8.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1872 -9.2680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4723 -9.6799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7617 -9.2680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7617 -8.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4724 -8.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0468 -9.6799 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.4723 -10.5037 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.6128 -6.7964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6975 -5.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5066 -5.8031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9185 -6.5179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3662 -7.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9504 -9.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7715 -9.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 1 0
6 8 2 0
6 9 1 0
4 7 1 0
11 12 2 0
11 13 1 0
13 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
18 21 1 0
17 22 1 0
13 15 1 0
10 11 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
23 27 1 0
14 23 1 0
2 10 1 0
28 29 1 0
9 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.41Molecular Weight (Monoisotopic): 454.0885AlogP: 5.86#Rotatable Bonds: 8Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.88CX Basic pKa: ┄CX LogP: 6.27CX LogD: 6.15Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.40
References 1. Haynes NE, Corbett WL, Bizzarro FT, Guertin KR, Hilliard DW, Holland GW, Kester RF, Mahaney PE, Qi L, Spence CL, Tengi J, Dvorozniak MT, Railkar A, Matschinsky FM, Grippo JF, Grimsby J, Sarabu R.. (2010) Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)., 53 (9): [PMID:20405948 ] [10.1021/jm100039a ]